Literature DB >> 35286145

Summary for Patients: Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments.

.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35286145      PMCID： PMC8949738          DOI： 10.7326/P22-0005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   51.598


× No keyword cloud information.
  1 in total

1.  Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study).

Authors:  Guillaume Martin-Blondel; Anne-Genevieve Marcelin; Cathia Soulié; Sofia Kaisaridi; Clovis Lusivika-Nzinga; Céline Dorival; Laura Nailler; Anaïs Boston; Cléa Melenotte; Géraldine Gaube; Christophe Choquet; Roland Liblau; Fabrice Carrat; Youri Yordanov
Journal:  J Infect       Date:  2022-04-07       Impact factor: 38.637
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.